232
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Reduced Serum Levels of Klotho are Associated with Mild Cognitive Impairment in Patients with Type 2 Diabetes Mellitus

, &
Pages 129-137 | Received 14 Nov 2022, Accepted 16 Dec 2022, Published online: 15 Jan 2023

References

  • Reed J, Bain S, Kanamarlapudi V. A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives. Diabetes Metab Syndr Obes. 2021;14:3567–3602.
  • Savonitto S, Morici N, Nozza A, et al. Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes. Diab Vasc Dis Res. 2018;15(1):14–23. doi:10.1177/1479164117735493
  • Ott A, Stolk RP, van Harskamp F, et al. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology. 1999;53:1937–1942. doi:10.1212/WNL.53.9.1937
  • Wang G, Li W. Diabetes as a risk factor for abnormal cognition development. J Alzheimers Dis Rep. 2020;4(1):237–242. doi:10.3233/ADR-200181
  • Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301:1565–1572. doi:10.1001/jama.2009.460
  • Ramos-Rodriguez JJ, Molina-Gil S, Ortiz-Barajas O, et al. Central proliferation and neurogenesis is impaired in type 2 diabetes and prediabetes animal models. PLoS One. 2014;9:e89229. doi:10.1371/journal.pone.0089229
  • Wrighten SA, Piroli GG, Grillo CA, et al. A look inside the diabetic brain: contributors to diabetes-induced brain aging. Biochim Biophys Acta. 2009;1792:444–453. doi:10.1016/j.bbadis.2008.10.013
  • Beauquis J, Saravia F, Coulaud J, et al. Prominently decreased hippocampal neurogenesis in a spontaneous model of type 1 diabetes, the nonobese diabetic mouse. Exp Neurol. 2008;210:359–367. doi:10.1016/j.expneurol.2007.11.009
  • Yu ZW, Liu R, Li X, et al. High serum neuron-specific enolase level is associated with mild cognitive impairment in patients with diabetic retinopathy. Diabetes Metab Syndr Obes. 2020;13:1359–1365. doi:10.2147/DMSO.S249126
  • Zhan C, Wang Q, Liu J, et al. Relationship between metabolic syndrome and cognitive function: a population-based study of middle-aged and elderly adults in Rural China. Diabetes Metab Syndr Obes. 2021;14:1927–1935. doi:10.2147/DMSO.S308250
  • Razzaque MS. The role of Klotho in energy metabolism. Nat Rev Endocrinol. 2012;8(10):579–587. doi:10.1038/nrendo.2012.75
  • Dalton GD, Xie J, An SW, et al. New insights into the mechanism of action of Soluble Klotho. Front Endocrinol. 2017;8:323. doi:10.3389/fendo.2017.00323
  • Torbus-Paluszczak M, Bartman W, Adamczyk-Sowa M. Klotho protein in neurodegenerative disorders. Neurol Sci. 2018;39(10):1677–1682. doi:10.1007/s10072-018-3496-x
  • Dubal DB, Yokoyama JS, Zhu L, et al. Life extension factor klotho enhances cognition. Cell Rep. 2014;7(4):1065–1076. doi:10.1016/j.celrep.2014.03.076
  • Donate-Correa J, Martín-Núñez E, Delgado NP, et al. Implications of Fibroblast growth factor/Klotho system in glucose metabolism and diabetes. Cytokine Growth Factor Rev. 2016;28:71–77. doi:10.1016/j.cytogfr.2015.12.003
  • Asai O, Nakatani K, Tanaka T, et al. Decreased renal α-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion. Kidney Int. 2012;81(6):539–547. doi:10.1038/ki.2011.423
  • Nie F, Wu D, Du H, et al. Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus. J Diabetes Complications. 2017;31(3):594–598. doi:10.1016/j.jdiacomp.2016.11.008
  • Adeli S, Zahmatkesh M, Tavoosidana G, et al. Simvastatin enhances the hippocampal klotho in a rat model of streptozotocin-induced cognitive decline. Prog Neuropsychopharmacol Biol Psychiatry. 2017;72:87–94. doi:10.1016/j.pnpbp.2016.09.009
  • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
  • Portet F, Ousset PJ, Visser PJ, et al. MCI Working Group of the European Consortium on Alzheimer’s Disease (EADC). Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s Disease. J Neurol Neurosurg Psychiatry. 2006;77(6):714–718. doi:10.1136/jnnp.2005.085332
  • Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699. doi:10.1111/j.1532-5415.2005.53221.x
  • Lu J, Li D, Li F, et al. Montreal cognitive assessment in detecting cognitive impairment in Chinese elderly individuals: a population-based study. J Geriatr Psychiatry Neurol. 2011;24(4):184–190. doi:10.1177/0891988711422528
  • Umegaki H, Hayashi T, Nomura H, et al. Cognitive dysfunction: an emerging concept of a new diabetic complication in the elderly. Geriatr Gerontol Int. 2013;13(1):28–34. doi:10.1111/j.1447-0594.2012.00922.x
  • Crane PK, Walker R, Larson EB. Glucose levels and risk of dementia. N Engl J Med. 2013;369(19):1863–1864. doi:10.1056/NEJMoa1215740
  • McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet. 2012;379(9833):2291–2299. doi:10.1016/S0140-6736(12)60360-2
  • Yokoyama JS, Marx G, Brown JA, et al. Systemic klotho is associated with KLOTHO variation and predicts intrinsic cortical connectivity in healthy human aging. Brain Imaging Behav. 2017;11(2):391–400. doi:10.1007/s11682-016-9598-2
  • Shardell M, Semba RD, Rosano C, et al. Plasma Klotho and cognitive decline in older adults: findings from the InCHIANTI Study. J Gerontol a Biol Sci Med Sci. 2016;71(5):677–682. doi:10.1093/gerona/glv140
  • Brombo G, Bonetti F, Ortolani B, et al. Lower Plasma Klotho concentrations are associated with vascular dementia but not late-onset alzheimer’s disease. Gerontology. 2018;64(5):414–421. doi:10.1159/000488318
  • Pan HC, Chou KM, Lee CC, et al. Circulating Klotho levels can predict long-term macrovascular outcomes in type 2 diabetic patients. Atherosclerosis. 2018;276:83–90. doi:10.1016/j.atherosclerosis.2018.07.006
  • Pappas C, Small BJ, Andel R, et al. Blood glucose levels may exacerbate executive function deficits in older adults with cognitive impairment. J Alzheimers Dis. 2019;67(1):81–89. doi:10.3233/JAD-180693
  • Lin Y, Sun Z. In vivo pancreatic β-cell-specific expression of antiaging gene Klotho: a novel approach for preserving β-cells in type 2 diabetes. Diabetes. 2015;64(4):1444–1458. doi:10.2337/db14-0632
  • Wang F, Zhao M, Han Z, et al. Long-term subclinical hyperglycemia and hypoglycemia as independent risk factors for mild cognitive impairment in elderly people. Tohoku J Exp Med. 2017;242(2):121–128. doi:10.1620/tjem.242.121
  • Sastre C, Rubio-Navarro A, Buendía I, et al. Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout mice. PLoS One. 2013;8(12):e83713. doi:10.1371/journal.pone.0083713